Filing Details

Accession Number:
0001144204-16-076463
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-21 13:54:10
Reporting Period:
2016-01-19
Filing Date:
2016-01-21
Accepted Time:
2016-01-21 13:54:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488039 Atossa Genetics Inc ATOS Surgical & Medical Instruments & Apparatus (3841) 264753208
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008227 C Steven Quay C/O Atossa Genetics, Inc.
2300 Eastlake Ave. East, Suite 200
Seattle WA 98102
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-19 50,000 $0.20 4,796,858 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. Represents 50,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
  2. Consists of: (i) 4,318,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"), and (ii) 478,543 shares of common stock owned directly by Dr. Quay. Shu-Chih Chen, Ph.D. and Dr. Quay share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Quay and Chen, and, as a result, Drs. Quay and Chen are deemed to be beneficial owners of the shares held by this entity.